UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K  

CURRENT REPORT

Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 4, 2016

TE CONNECTIVITY LTD.

(Exact name of registrant as specified in its charter)

Rheinstrasse 20

CH-8200 Schaffhausen

Switzerland

+41 (0)52 633 66 61

(Registrant’s telephone number, including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01.  Other Events

On February 2, 2016, TE Connectivity Ltd., a Swiss corporation (“TE” or the “Company”), announced that it had entered into a Share Purchase Agreement (the “Share Purchase Agreement”) with Cregstar Holdco Limited, a non-cellular company limited by shares incorporated under the Laws of the Island of Guernsey (the “Seller”), to acquire the Creganna Medical group of companies through the purchase of 100% of the equity of Cregstar Bidco Limited together with certain loan notes (the “Transaction”).  On April 4, 2016, the Company and the Company’s indirect wholly-owned subsidiaries, TE Connectivity Ireland Ltd. and Tyco Electronics Group S.A., consummated the Transaction.  The Company paid an aggregate cash purchase price of $895 million, which is subject to customary adjustments for cash, working capital, indebtedness and transaction expenses.

A copy of the press release announcing the completion of the Transaction is attached as Exhibit 99.1 and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

3